William Blair & Company’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,412
| Closed | -$17.5K | – | 1862 |
|
|
2023
Q1 | $17.5K | Sell |
2,412
-652
| -21% | -$4.73K | ﹤0.01% | 1692 |
|
|
2022
Q4 | $34.5K | Hold |
3,064
| – | – | ﹤0.01% | 1622 |
|
|
2022
Q3 | $40K | Hold |
3,064
| – | – | ﹤0.01% | 1626 |
|
|
2022
Q2 | $39K | Hold |
3,064
| – | – | ﹤0.01% | 1654 |
|
|
2022
Q1 | $176K | Hold |
3,064
| – | – | ﹤0.01% | 1549 |
|
|
2021
Q4 | $364K | Buy |
3,064
+976
| +47% | +$116K | ﹤0.01% | 1342 |
|
|
2021
Q3 | $415K | Hold |
2,088
| – | – | ﹤0.01% | 1227 |
|
|
2021
Q2 | $363K | Hold |
2,088
| – | – | ﹤0.01% | 1274 |
|
|
2021
Q1 | $413K | Hold |
2,088
| – | – | ﹤0.01% | 1206 |
|
|
2020
Q4 | $411K | Hold |
2,088
| – | – | ﹤0.01% | 1148 |
|
|
2020
Q3 | $370K | Hold |
2,088
| – | – | ﹤0.01% | 1058 |
|
|
2020
Q2 | $483K | Buy |
2,088
+1,000
| +92% | +$231K | ﹤0.01% | 951 |
|
|
2020
Q1 | $127K | Hold |
1,088
| – | – | ﹤0.01% | 1276 |
|
|
2019
Q4 | $208K | Hold |
1,088
| – | – | ﹤0.01% | 1294 |
|
|
2019
Q3 | $209K | Hold |
1,088
| – | – | ﹤0.01% | 1251 |
|
|
2019
Q2 | $186K | Hold |
1,088
| – | – | ﹤0.01% | 1323 |
|
|
2019
Q1 | $219K | Hold |
1,088
| – | – | ﹤0.01% | 1267 |
|
|
2018
Q4 | $204K | Hold |
1,088
| – | – | ﹤0.01% | 1227 |
|
|
2018
Q3 | $260K | Hold |
1,088
| – | – | ﹤0.01% | 1201 |
|
|
2018
Q2 | $288K | Hold |
1,088
| – | – | ﹤0.01% | 1143 |
|
|
2018
Q1 | $270K | Buy |
1,088
+640
| +143% | +$159K | ﹤0.01% | 1103 |
|
|
2017
Q4 | $61K | Hold |
448
| – | – | ﹤0.01% | 1325 |
|
|
2017
Q3 | $55K | Hold |
448
| – | – | ﹤0.01% | 1322 |
|
|
2017
Q2 | $43K | Buy |
+448
| New | +$43K | ﹤0.01% | 1399 |
|